The present disclosure relates to an apparatus and method for delivering an implantable medical device, particularly a stent graft.
The statements in this section merely provide background information related to the present disclosure and may not constitute prior art.
In aortic intervention, stented endovascular grafts are currently used for the treatment of aneurysms and aortic dissections. Stent grafts are commonly placed into such diseased vessels for structural support and to exclude blood flow to aneurysms. Therefore, they may be able to reduce or prevent further vessel expansion, and thus can reduce the likelihood of aneurysm rupture.
Proper placement of stent grafts aids in the success of such treatments. Good wall apposition and anchoring can help to reduce the occurrence of Type I and Type III endoleaks.
Different release mechanisms are currently used in endovascular graft delivery devices to unfold and/or attach stent grafts to vessel walls. These stents may include top stents that are located at an end of the endovascular graft, distal stents, and other stents that are located within the main body of the endovascular graft. As most stents used in these devices have barbs that attach to the vessel, the slow or controlled release of these stents or stented grafts can allow for accurate placement of the graft. If these stents are released without a controlled release mechanism during unsheathing, immediate engagement of the barbs is possible, which in turn may prevent readjustment of the positioning of the endograft.
Many such release mechanisms employ wires (such as nickel/titanium or stainless steel wires) to activate the release of the stent or stent graft. This release mechanism is designed such that it is easy to use, that it has a low profile, and that it functions reliably.
It has been a challenge to develop a medical device delivery assembly that quickly and reliably releases a stent graft or a stent thereof in such a way that the graft is repositionable.
According to one aspect of the present disclosure, a system for deploying at least a portion of a stent is described. The system may include a cannula comprising a lumen. The system may include a guide member disposed over the cannula. The guide member may include an outer surface, and the guide member may define at least one curved channel therein. The at least one curved channel may define a trigger wire lumen. The guide member may include at least one access port through the outer surface to the curved channel. The system may include a trigger wire disposed in the trigger wire lumen.
According to another aspect of the present disclosure, a medical device assembly is described. The medical device assembly may include a cannula comprising a lumen, which may be a wire guide lumen. The medical device assembly may include a guide member disposed over the cannula. The guide member may have an outer surface and may comprise at least one curved channel therein. The at least one curved channel may define a trigger wire lumen which may be distinct from, or not in fluid communication with, the wire guide lumen. The guide member may include at least one access port through the outer surface to the curved channel. The medical device assembly may include a trigger wire disposed in the trigger wire lumen defined by the curved channel. The medical device assembly may include at least one loop disposed about the trigger wire and extending through the access port. The medical device assembly may include a stent graft disposed about the cannula, the stent graft including an end stent having an apex. The apex of the end stent may extend through the loop.
According to another aspect of the present disclosure, a method of delivering a stent graft is provided. The method may include moving a trigger wire distally in a medical device assembly that includes a trigger wire surrounded by a loop, the loop restraining an apex of an end stent of the stent graft. Moving the trigger wire distally such that the trigger wire passes completely through the loop may cause the apex to no longer be restrained. The method may include, when the trigger wire is moved distally, a plurality of apices being sequentially released. The method may include, when the trigger wire is moved distally, a plurality of apices being simultaneously released.
Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.
In order that the disclosure may be well understood, there will now be described various forms thereof, given by way of example, reference being made to the accompanying drawings, in which:
The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way.
The following description is merely exemplary in nature and is not intended to limit the present disclosure, application, or uses. It should be understood that throughout the drawings, corresponding reference numerals indicate like or corresponding parts and features.
In the present application, the term “proximal end” is used when referring to that end of a medical device closest to the heart after placement in the human body of the patient, and may also be referred to as the inflow end (the end that receives fluid first), and the term “distal end” is used when referring to that end opposite the proximal end, or the one farther from the heart after its placement, and may also be referred to as the outflow end (that end from which fluid exits).
Although numerous examples of trigger wire/release systems for the delivery of stent grafts exist and have been commercialized, such systems generally involve the direct connection of the device to be delivered to the delivery system. A release mechanism that secures a portion of the device indirectly to the delivery system may provide increased freedom of motion to the portion of the device to which it is connected. In some examples, the portion of the device that is connected may be a top stent; that is, the most proximal stent of the stent graft, which in some cases may be a suprarenal stent. However, other portions of the device, including other stents, may also be connected to the delivery system. Such indirect connection may also provide for a simplified release mechanism, including reducing the total number of trigger wires used in the delivery assembly.
An assembly providing for indirect connection between the device to be delivered and the assembly itself may provide for better control of release of the device in the body of the patient, and may also allow for greater freedom of movement of the device during delivery. Freedom of transverse, axial and rotational movement within the confines of the vessel walls can allow the device to conform itself to the natural vessel angulations, which in turn can improve wall apposition and sealing at the downstream stent sealing zone, and can reduce uneven localized forces experienced on barbs and at attachment sites, thereby reducing the changes of type I and type III endoleaks, perhaps even preventing them altogether.
As used herein, the term “direct” when used in reference to a connection between a stent portion of a stent graft to be released by a trigger wire and the trigger wire of the stent graft delivery assembly itself means that the trigger wire contacts the stent portion of the stent graft without contacting an intermediate component. “Indirect” means that the contact between the trigger wire and the stent portion of the stent graft to be released by the trigger wire is bridged by at least one additional component that is not the trigger wire and is not the stent portion of the stent graft.
In the delivery assembly 210 as shown in
The trigger wires 240a/240b may extend out of the cannula 220 via openings 222a/222b, respectively (222b being on the opposite face of the cannula 220 as illustrated, not shown). The trigger wire 240a then enters an entry port 266a in the guide member 260 and extends proximally and in a helical fashion through a channel 262a (which itself is curved, or helical) in the interior of guide member 260, as will be described later in this disclosure. The channel 262a may have a series of openings (264a/264b/264c in the variation as illustrated in
In the illustrated delivery assembly 210 of
In another aspect, the delivery assembly may have a cross-section as illustrated in
In the illustrated aspect, the top stent 232 of stent graft 230 has six apices 234a-234f, and the two trigger wires 240a/240b of delivery assembly 210 each pass by three openings (256a-256c and 256d-256f) in the guide member 260, providing six total openings, one for each apex of the top stent 232. In some aspects, the delivery assembly 210 may be constructed to have a number of openings equal to the number of apices of the top stent of the endograft to be delivered by the delivery assembly. Those of skill in the art will appreciate that designs having differing numbers of trigger wires, openings in the guide member, and channels formed in the guide member can be constructed in accordance with the principles of the present disclosure, depending on the specific application for which the delivery assembly is intended.
The guide member 260 may be of solid construction, aside from the channels 262a and 262b, or may have hollow portions other than the channels 262a/262b. As illustrated, the guide member 260 has a substantially ellipsoid shape, but other shapes may be suitable as well, including spherical, rounded prismatic, and so forth. The channels 262a/262b may be machined in a solid piece of precursor material, or it may be additively manufactured to precisely control the size and shape of the channels for the trigger wires. The guide member 260 may be constructed without sharp edges at either end such that it will not damage the graft or the vessel during operation.
The guide member 260 may be made of any suitable material. In one aspect, the guide member 260 may be made of a metal, including but not limited to stainless steel, titanium, and other metals or metal alloys with biocompatible and hemocompatible properties. In another example, polymers including polyether ether ketone (PEEK), polyoxymethylene (DELRIN), polyethylene, and other biocompatible and hemocompatible polymers with comparable properties may be used.
As shown in
The loops 250, when engaged with the stent apices 234 of the top stent 232 of the stent graft 230 and the trigger wire 240 of the delivery assembly 210, define an attached state (or delivery state) for the stent graft 230. This attached state allows freedom of motion to the stent apex such that it can move transversely, axially, and partially rotate about the cannula 220 so that this motion may enable the main body of the stent graft 230 (especially the proximal sealing section) to conform to the vessel wall during unsheathing of the graft prior to stent release by the trigger wires 240a/240b. This is in contrast to known assemblies, particularly abdominal aortic aneurysm (AAA) stent grafts having a suprarenal stent, wherein the orientation of the delivery assembly in the vessel plays a larger role in governing the orientation of the remainder of the graft in the vessel, which in some cases may reduce efficiency in sealing and less perfect vessel wall apposition upon deployment.
The loops 250 may be made from any suitable biocompatible material. For instance, they may be made of a nondegradable suture material, including but not limited to polypropylene, polyester, Dyneema, or another hemocompatible pure or blended material. The loops 250 may also be made of a biocompatible or hemocompatible wire, such as one made from a nickel/titanium alloy or stainless steel.
An end portion of another delivery assembly 910 is illustrated in
The sleeve 925 may be made of a biocompatible polymer, and may fit tightly enough to restrain the trigger wires 940a/940b in the radial dimension, but loosely enough that it does not interfere with movement in the longitudinal dimension when the trigger wires 940a/940b are manipulated. In this way, the trigger wires 940a/940b may contact, or run along the length of, the cannula 920 when the sleeve 925 is employed. The sleeve 925 may extend over opening 922a and may extend over portions of the trigger wires 940a/940b. In some aspects, the sleeve 925 may have a hole through it for positioning over or substantially over the opening 922a, to allow the trigger wires 940a/940b to pass through.
As illustrated in
The guide member 960 may be attached or fixed to the cannula 920, which may be made of a metal; to the sleeve 925 which may be made of a plastic or a polymer; or to both the cannula 920 or the sleeve 925.
The various delivery assemblies illustrated and described throughout this explanation may optionally include a sleeve similar to sleeve 925. For clarity, the sleeve has been omitted in figures other than
A number of variations on loops may be useful for indirect connection of the stent graft to the delivery assembly according to the principles of the present disclosure. In one aspect, and as shown in
In a variation shown in
A full view of an exemplary delivery system 500 is shown in
In some aspects, the stent graft may be crimped over the delivery assembly, and/or may be held in place by a sleeve positioned over the system including the stent graft and the delivery assembly.
A delivery system constructed in accordance with the principles of the present disclosure may provide a number of structural features that allow for varying release schemes. In system 600 shown in
The delivery system 700 of
In another aspect, delivery system 800, shown in
In one release scheme, trigger wire 840a may first be pulled distally to allow the top stent 832 a greater degree of movement and/or expansion in the radial dimension. This may effectively cause a partial expansion of the stent graft 830, so that the final position of the stent graft 830 can be approximated in the vasculature of the patient, and repositioned by the practitioner as necessary. The second trigger wire 840b can then be pulled distally to fully release the stent graft 830 such that it fully expands in the body vessel of the patient. Such a stepwise release may reduce the chances that a barb prematurely engages the vessel wall.
Features of any of the systems 600/700/800 may be used in combination with any of the other systems 600/700/800 according to the intended application.
Although the present disclosure has been described with reference to examples and the accompanying drawings, the present disclosure is not limited thereto, but may be variously modified and altered by those skilled in the art to which the present disclosure pertains without departing from the spirit and scope of the present disclosure.
This invention claims the benefit of priority of U.S. Provisional Application Ser. No. 62/939,219, entitled “Stent Graft Trigger with Indirect Fixation,” filed Nov. 22, 2019, the disclosure of which is hereby incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
62939219 | Nov 2019 | US |